Financial statements Pharma Partner
Balance sheet data of PHARMA PARTNER
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 639 428,68 | 1 806 347,55 | 1 638 422,26 | 2 718 194,51 | 8 783 303,63 | 6 287 411,13 |
| A. Fixed assets | 576 242,37 | 811 030,12 | 1 010 715,60 | 1 349 121,53 | 1 726 580,62 | 462 382,48 |
| B. Current assets | 2 063 186,31 | 995 317,43 | 627 706,66 | 1 369 072,98 | 7 056 723,01 | 5 825 028,65 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 639 428,68 | 1 806 347,55 | 1 638 422,26 | 2 718 194,51 | 8 783 303,63 | 6 287 411,13 |
| A. Equity | 2 294 761,95 | 1 388 990,83 | 429 274,55 | 1 556 964,48 | 6 786 425,79 | -740 406,75 |
| B. Liabilities and provisions for liabilities | 344 666,73 | 417 356,72 | 1 209 147,71 | 1 161 230,03 | 1 996 877,84 | 7 027 817,88 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 190 496,42 | 284 760,68 | 992 337,21 | 902 618,40 | 1 180 488,33 | 6 426 976,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.